… The viral infection could also further promote inhibition of inflammatory signaling pathways
causing immunosuppression [Citation57]. Recently, Bouwman and colleagues reported that …

… NF-kB has been considered as a therapeutic target for COVID-19 patients [17]. Therefore,
we evaluated whether the NF-kB pathway was activated in the kidney of COVID-19 patients. p-…

… Camostat Mesylate and nafamostat mesylate are serine protease inhibitors used to treat
pancreatitis and inflammatory diseases could be used to combat NF-κB signalling pathway. …

… targeting the IL-6 signalling pathway has been identified as a … hyperinflammation associated
with COVID-19. However, to … target the IL-6 signalling pathway in patients with COVID-19. …

… from patients with COVID-19 pneumonia, COVID-19 ARDS, … With bioinformatically constructed
canonical pathways … differences in molecular signaling between COVID-19 and other …

… pathways and systems involved in the pathophysiology and immunopathogenesis of
COVID-19. … Inhibition of the TLR signalling pathway and thereby decreased cytokine production …

… inflammatory signaling and oxidative stress pathways resulting in … of COVID-19 patients,
we observed increased systemic oxidative stress and activation of the TGF-β signaling pathway …

… An emphasis will be put on host cellular signaling pathways and proteases involved with
a … COVID-19 is a respiratory disease whose aetiologic agent is a novel beta coronavirus (CoV) …

… the TLR4 signaling pathway. Studies have shown that NET formation in COVID-19 patients
… has a higher level in COVID-19 patients and also TLR4 pathway activation in the pulmonary …

… cytokine expression is not the cause of compromised respiratory function in COVID-19 …
signaling pathway suggests that COVID-19 pathogenesis may be driven by this pathway. If this is …